INDIVIDUAL DRUG MONOGRAPHS APPENDIXES A. Selected New Drugs abametapir aducanumab-avwa afamelanotide anifrolumab-fnia asciminib atogepant avacopan avapritinib belumosudil belzutifan bempedoic acid brolucizumab-dbll difelikefalin dostarlimab-gxly eculizumab efavirenz/emtricitabine/tenofovir elapegademase-ivir elbasvir/grazoprevir elexacaftor/tezacaftor/ivacaftor and ivacaftor emtricitabine/rilpivirine/tenofovir alafenamide enalapril/hydrochlorothiazide ephedrine factor IX complex factor IX, human factor IX, recombinant finerenone fluocinolone fluocinonide lonapegsomatropin-tcgd loncastuximab tesirine-lpyl maribavir mobocertinib odevixibat ropeginterferon alfa-2b tisotumab vedotin-tftv vosoritide B. Ophthalmic, Nasal, Topical, and Otic Products C. Vaccines and Toxoids D. Recent FDA Drug Approvals INDEX EVOLVE WEBSITE . Additional Monographs . Drug Categories
Linda Skidmore-Roth, RN, MSN, NP has been the lead author of Mosby's Nursing Drug Reference for more than 25 years and as such is synonymous with the Mosby imprint as a trusted name in nursing pharmacology information